Yoo_Thuluvath_Maheshwari_Headshot_Labcoat_Bunting_Lobby_11.15.2018_GILiverSpecialists_007-004.jpg

Transjugular Intrahepatic Portosystemic Shunt Offered as Treatment Option for Portal Hypertension

Patients from across the Baltimore Metropolitan region seek the expertise of Dr. Paul Thuluvath, Dr. Anurag Maheshwari and Dr. Hwan Yoo for their innovative treatment options for liver disease. At The Center for Liver and Hepatobiliary Diseases at Mercy, our doctors are proud to offer the transjugular intrahepatic portosystemic shunt as a treatment option for portal hypertension.

What is a Transjugular Intrahepatic Portosystemic Shunt (TIPS)?

Transjugular intrahepatic portosystemic shunt is a minimally invasive procedure in which a stent is placed in the liver’s veins. A transjugular intrahepatic portosystemic shunt enables the blood flow to bypass the liver and release pressure that can build in the portal vein due to portal hypertension.

When is a Transjugular Intrahepatic Portosystemic Shunt (TIPS) a treatment option?

A transjugular intrahepatic portosystemic shunt is a treatment option for portal hypertension, a complication of severe liver disease.

The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy provides diagnosis and treatment for a range of gastroenterology issues including heartburn, liver disease, bowel conditions, motility disorders and pancreatic disease.